The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs

E-ISSN： 1873-5592|14|11|1277-1294

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.11, 2013-01, pp. : 1277-1294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Currently Available Drugs for the Treatment of Obesity: Sibutramine and Orlistat

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 3-10

Bentham Science Publishers

Access to resources Recommend Favorite

Neurogenesis as a New Target for the Development of Antidepressant Drugs

Current Pharmaceutical Design, Vol. 20, Iss. 23, 2014-05 ,pp. : 3763-3775

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: New Antidepressant Drugs: Beyond Monoaminergic Mechanisms (Executive Editors: Cecilio Alamo and Francisco Lopez-Munoz)]

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1559-1562

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1688-1698

Bentham Science Publishers

Access to resources Recommend Favorite

A safety look at currently available statins

By Moghadasian Mohammed H

Expert Opinion on Drug Safety, Vol. 1, Iss. 3, 2002-09 ,pp. : 269-274

Informa Healthcare

Access to resources Recommend Favorite